{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T04:02:27Z","timestamp":1746417747609,"version":"3.40.4"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"24","license":[{"start":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T00:00:00Z","timestamp":1623974400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Kunlun Elite, High-End Innovation and Entrepreneurship Talents of Qinghai Province","award":["2020"],"award-info":[{"award-number":["2020"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Globally, coronary heart disease (CHD) is a primary cause of morbidity leading to disabilities and mortality. Modern clinical practice adopts several pharmacological methods to treat CHD. Angina pectoris refers to sever chest pain due to CHD, it has a profound impact on the wellbeing of patients. Moreover, angina pectoris is a crucial prognosis predictor. The aim of the current study is to evaluate the effectiveness and safeness of using combined rosuvastatin and atorvastatin to treat CHD patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A systematic literature search for articles will be conducted on several electronic databases from their inception to May 2021. The search will include all randomized controlled trials examining the use of rosuvastatin in combination with atorvastatin to treat CHD patients. The databases are as follows: MEDLINE, Web of Science, the Cochrane Library, WanFang database, China National Knowledge Infrastructure, and EMBASE. A couple of authors will independently assess the eligibility, extract study data, and assess the possibility of bias. Moreover, depending on the type of data and heterogeneity of the included studies, either the Mantel\u2013Haensel fixed-effect model or the DerSimonian-Laird random-effect model will be used to estimate the relative risk, mean differences, or standardized mean differences and 95% confidence intervals. All differences in opinion shall be decided by involving an additional author in the discussion. Lastly, the RevMan software (version: 5.3) will be used to perform sensitivity analysis, data synthesis, and risk of bias assessment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The effectiveness and security of using rosuvastatin in combination with atorvastatin to treat CHD patients will be systematically evaluated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>This study will provide evidence to evaluate the efficacy and security of using a combination of rosuvastatin and atorvastatin to treat CHD patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Ethics and dissemination:<\/jats:title>\n            <jats:p>Ethical approval will not be required since it is based on already published data.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Registration number:<\/jats:title>\n            <jats:p>DOI 10.17605\/OSF.IO\/VYBDR (https:\/\/osf.io\/vybdr\/).<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000026340","type":"journal-article","created":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T14:03:36Z","timestamp":1623938616000},"page":"e26340","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Evaluation of efficacy and safety of combined rosuvastatin and atorvastatin in treating with coronary heart disease"],"prefix":"10.1097","volume":"100","author":[{"given":"Ke","family":"Li","sequence":"first","affiliation":[{"name":"Department of Hematology, the Affiliated Hospital of Qinghai University, Xining, Qinghai"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-Meng","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Hematology, the Affiliated Hospital of Qinghai University, Xining, Qinghai"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Hematology, the Affiliated Hospital of Qinghai University, Xining, Qinghai"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, the Wanyuan Central Hospital, Wanyuan, Sichuan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Geng","sequence":"additional","affiliation":[{"name":"Department of Hematology, the Affiliated Hospital of Qinghai University, Xining, Qinghai"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Hematology, the Affiliated Hospital of Qinghai University, Xining, Qinghai"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4521-0218","authenticated-orcid":false,"given":"Jie","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Hematology, the Affiliated Hospital of Qinghai University, Xining, Qinghai"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,6,18]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1136\/hrt.2007.118323","article-title":"Coronary heart disease trends in England and Wales from 1984 to 2004: concealed levelling of mortality rates among young adults","volume":"94","author":"O\u2019Flaherty","year":"2008","journal-title":"Heart"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.tcm.2015.03.001","article-title":"Recent findings of long-chain n-3 polyunsaturated fatty acids (LCn-3 PUFAs) on atherosclerosis and coronary heart disease (CHD) contrasting studies in Western countries to Japan","volume":"25","author":"Sekikawa","year":"2015","journal-title":"Trends Cardiovasc Med"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/CIRCRESAHA.117.308903","article-title":"Reducing the global burden of cardiovascular disease, part 1: the epidemiology and risk factors","volume":"121","author":"Joseph","year":"2017","journal-title":"Circ Res"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nature00804","article-title":"Subendothelial retention of atherogenic lipoproteins in early atherosclerosis","volume":"417","author":"Sk\u00e5l\u00e9n","year":"2002","journal-title":"Nature"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1161\/CIRCULATIONAHA.106.676890","article-title":"Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications","volume":"116","author":"Tabas","year":"2007","journal-title":"Circulation"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis--an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and stroke statistics-2020 update: a report from the American Heart Association","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1016\/j.jacc.2020.11.021","article-title":"The global burden of cardiovascular diseases and risks: a compass for global action","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12933-020-01022-7","article-title":"Report from the 5th cardiovascular outcome trial (CVOT) summit","volume":"19","author":"Schnell","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"i721","DOI":"10.1136\/bmj.i721","article-title":"Primary prevention and risk factor reduction in coronary heart disease mortality among working aged men and women in eastern Finland over 40\u200ayears: population based observational study","volume":"352","author":"Jousilahti","year":"2016","journal-title":"BMJ"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur Heart J"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1177\/1741826711400545","article-title":"Persistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and Canada","volume":"19","author":"Gitt","year":"2012","journal-title":"Eur J Prev Cardiol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"628","DOI":"10.4093\/dmj.2011.35.6.628","article-title":"Low density lipoprotein cholesterol target goal attainment rate and physician perceptions about target goal achievement in Korean patients with diabetes","volume":"35","author":"Hwang","year":"2011","journal-title":"Diabetes Metab J"},{"key":"R16-20250504","first-page":"420","article-title":"The second multi-center survey of dyslipidemia management in China: goal attainment rate and related factors","volume":"35","author":"Wu","year":"2007","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3904\/kjim.2010.25.1.27","article-title":"Comparative study of low doses of rosuvastatin and atorvastatin on lipid and glycemic control in patients with metabolic syndrome and hypercholesterolemia","volume":"25","author":"Park","year":"2010","journal-title":"Korean J Intern Med"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1253\/circj.CJ-10-1281","article-title":"Randomized head-to-head comparison of pitavastatin, atorvastatin, and rosuvastatin for safety and efficacy (quantity and quality of LDL): the PATROL trial","volume":"75","author":"Saku","year":"2011","journal-title":"Circ J"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000026340","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:40:31Z","timestamp":1746337231000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000026340"}},"subtitle":["A protocol for systematic review and meta-analysis"],"short-title":[],"issued":{"date-parts":[[2021,6,18]]},"references-count":17,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000026340","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2021,6,18]]},"assertion":[{"value":"2021-05-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}